When exploring the structural biology of th EGFR epidermal growth factor receptor [ (human)] e EGFR peptide sequence, one quickly realizes that this field is a fascinating intersection of computational design and protein chemistry. As an enthusiast who studies peptide interactions, I have found that understanding the nuances of the EGFR (Epidermal Growth Factor Receptor) structure is essential for anyone interested in how these amino acid chains function within complex biological systems.
The Canonical Sequence and Structural Architecture
The EGFR_HUMAN protein, also known as Er EGFR epidermal growth factor receptor [ (human)] bB-1 or HER1, is a massive transmembrane protein consisting of 1,210 amino acids. When looking at the isoform 1 (p170) is the canonical sequence of EGFR, it is clear why it remains a central subject of study. This receptor is a member of the e Design and synthesis of peptide-drug conjugates to double pider MAPK/ERK pathway - Wikipedia mal growth factor receptor (HER) family, which includes Her-2/ErbB-2, Her-3, and Her-4.
From a technical standpoint, the EGFR kinase domain can be activated by increasing its local concentration, a phenomenon that highlights the importance of spatial orientation. Researchers often utilize specific fragments, such as the amino acid peptide fragment derived from positions 985-996, to map out binding affinities.
Innovations in Peptide Targeting
The development of specialized ligands has revolutionized how we view these receptors. For instance, EGFR-targeting peptides were developed by different groups using diverse methodologies. One of the most frequently cited examples is Peptide 1 (or GE11, Table 1), a dodecapeptide known for its specific binding capability. Unlike some other ligands, the EGFR-binding peptide GE11 is particularly interesting because it demonstrates how a peptide can be engineered for precision without necessarily triggering the standard activation pathways.
Furthermor Small Peptide Ligands for Targeting EGFR in Triple e, recent advancements have introduced EGFRp1 and EGFRp4 peptides, which were identified through ribosome display techniques. These 11-mer sequences showcase the potential for high-affinity binding against the extracellular domain of the receptor.
Practical Data and Sequences
When analyzing the Homo sapiens epidermal growth factor receptor mRNA data, one encounters specific sequences that define the receptor's function. I have often referenced the Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Lys sequence, which is a well-documented EGFR-derived peptide with a molecular weight of approxim by S Bogdan·2001·Cited by 318—Its extracellular domain is characterized by two cysteine-rich motifs (CR I and CRII). DER and Let-23 have an additional CRIII domain. The overallamino acidRead more ately 1579.78 Da.
The complexity of these interactions is further illustrated by the EGFR ligands epiregulin (EREG) and epigen (EPGN), which stabilize unique dimeric conformations. It is a fundamental truth that EGFR is a cell surface protein that binds to epidermal growth factor, and the amino acid sequences involved in these interfaces determine the stability and efficacy of the resulting complex.
Final Thoughts on Research Methodology
Whether you are reviewing the sequence of a novel synthetic ligand or analyzing the EGFR kinase domain, the precision of the amino acid composition is paramount. The study of these receptors continues to evolve as new peptide designs emerge. By focusing on the structural biology and the specific binding motifs, we gain a deeper appreciation for the intricate design of the EGFR system.
It is always rewarding to see how researchers refine these amino acid sequences to achieve better selectivity, ensuring that the study of these proteins remains at the forefront of biochemical exploration.